251 related articles for article (PubMed ID: 7519132)
1. Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery.
Rocha E; Hidalgo F; Llorens R; Melero JM; Arroyo JL; Páramo JA
Circulation; 1994 Aug; 90(2):921-7. PubMed ID: 7519132
[TBL] [Abstract][Full Text] [Related]
2. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
[TBL] [Abstract][Full Text] [Related]
3. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
[TBL] [Abstract][Full Text] [Related]
4. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study.
Casas JI; Zuazu-Jausoro I; Mateo J; Oliver A; Litvan H; Muñiz-Díaz E; Arís A; Caralps JM; Fontcuberta J
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1107-17. PubMed ID: 7475139
[TBL] [Abstract][Full Text] [Related]
5. Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?
Rocha E; Llorens R; Páramo JA; Arcas R; Cuesta B; Trenor AM
Circulation; 1988 Jun; 77(6):1319-23. PubMed ID: 3286039
[TBL] [Abstract][Full Text] [Related]
6. Con: desmopressin is not of value in the treatment of post-cardiopulmonary bypass bleeding.
Hackmann T; Naiman SC
J Cardiothorac Vasc Anesth; 1991 Jun; 5(3):290-3. PubMed ID: 1863751
[TBL] [Abstract][Full Text] [Related]
7. Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults.
Wademan BH; Galvin SD
Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):360-70. PubMed ID: 24263581
[TBL] [Abstract][Full Text] [Related]
8. Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin.
Basora M; Gomar C; Escolar G; Pacheco M; Fita G; Rodriguez E; Ordinas A
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):382-7. PubMed ID: 10468248
[TBL] [Abstract][Full Text] [Related]
9. Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant Group.
Gu YJ; de Haan J; Brenken UP; de Boer WJ; Prop J; Van Oeveren W
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):599-606. PubMed ID: 8800145
[TBL] [Abstract][Full Text] [Related]
10. Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets.
Orchard MA; Goodchild CS; Prentice CR; Davies JA; Benoit SE; Creighton-Kemsford LJ; Gaffney PJ; Michelson AD
Br J Haematol; 1993 Nov; 85(3):533-41. PubMed ID: 7510990
[TBL] [Abstract][Full Text] [Related]
11. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release.
Ashraf S; Tian Y; Cowan D; Nair U; Chatrath R; Saunders NR; Watterson KG; Martin PG
Ann Thorac Surg; 1997 Jan; 63(1):68-73. PubMed ID: 8993243
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic activity and bleeding after cardiac surgery with cardiopulmonary bypass and low-dose aprotinin therapy.
Kuepper F; Dangas G; Mueller-Chorus A; Kulka PM; Zenz M; Wiebalck A
Blood Coagul Fibrinolysis; 2003 Feb; 14(2):147-53. PubMed ID: 12632024
[TBL] [Abstract][Full Text] [Related]
13. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery.
Mössinger H; Dietrich W; Braun SL; Jochum M; Meisner H; Richter JA
Ann Thorac Surg; 2003 Feb; 75(2):430-7. PubMed ID: 12607650
[TBL] [Abstract][Full Text] [Related]
14. Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass.
Harder MP; Eijsman L; Roozendaal KJ; van Oeveren W; Wildevuur CR
Ann Thorac Surg; 1991 Jun; 51(6):936-41. PubMed ID: 1710098
[TBL] [Abstract][Full Text] [Related]
15. Mini-dose pump-prime aprotinin inhibited enhanced fibrinolytic activity and reduced blood loss and transfusion requirements after coronary artery bypass surgery.
Kunt AS; Darcin OT; Aydin S; Demir D; Selli C; Andac MH
J Thromb Thrombolysis; 2005 Jun; 19(3):197-200. PubMed ID: 16082607
[TBL] [Abstract][Full Text] [Related]
16. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
Mastroroberto P; Chello M; Zofrea S; Marchese AR
Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
[TBL] [Abstract][Full Text] [Related]
17. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial.
Hedderich GS; Petsikas DJ; Cooper BA; Leznoff M; Guerraty AJ; Poirier NL; Symes JF; Morin JE
Can J Surg; 1990 Feb; 33(1):33-6. PubMed ID: 2405964
[TBL] [Abstract][Full Text] [Related]
18. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
[TBL] [Abstract][Full Text] [Related]
19. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
[TBL] [Abstract][Full Text] [Related]
20. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study.
Marquez J; Koehler S; Strelec SR; Benckart DH; Spero JA; Cottington EM; Torpey DJ
J Cardiothorac Vasc Anesth; 1992 Dec; 6(6):674-6. PubMed ID: 1472662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
